Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Core Laboratories (CLB) Revenue (2022 - 2025)

Core Laboratories' Revenue history spans 4 years, with the latest figure at $138.3 million for Q4 2025.

  • For Q4 2025, Revenue rose 6.98% year-over-year to $138.3 million; the TTM value through Dec 2025 reached $526.5 million, up 0.51%, while the annual FY2025 figure was $526.5 million, 0.51% up from the prior year.
  • Revenue reached $138.3 million in Q4 2025 per CLB's latest filing, up from $134.5 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $138.3 million in Q4 2025 to a low of $120.9 million in Q2 2022.
  • Average Revenue over 4 years is $129.0 million, with a median of $128.4 million recorded in 2023.
  • Peak YoY movement for Revenue: increased 7.22% in 2024, then dropped 4.67% in 2025.
  • A 4-year view of Revenue shows it stood at $127.6 million in 2022, then increased by 0.5% to $128.2 million in 2023, then grew by 0.8% to $129.2 million in 2024, then grew by 6.98% to $138.3 million in 2025.
  • Per Business Quant, the three most recent readings for CLB's Revenue are $138.3 million (Q4 2025), $134.5 million (Q3 2025), and $130.2 million (Q2 2025).